GZPHF Stock: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock Price, Analysis & Insights
Get live GZPHF stock price $2.34, comprehensive Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited stock analysis, charts, news, and expert forecast. Real-time GZPHF stock data and investment insights.
Loading chart data...
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) Overview
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, GZPHF trades at $2.34 with a market capitalization of 6.20B . Over the past 52 weeks, GZPHF has traded between $2.14 and $2.88 , with the current price positioned...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 6.20B
- Current price: $2.34
- 52-week range: $2.14 - $2.88
- P/E ratio: 9.00
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF), operating with its various subsidiaries, is a diversified pharmaceutical conglomerate primarily engaged in the research, development, manufacturing, and global distribution of a br...
Company Information
- CEO
- Hong Li
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 28138
Contact Information
- Website
- https://www.gybys.com.cn
- Address
- 45 Sha Mian North Street
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 9.0)
✓ Lower volatility stock (Beta: 0.24) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
- ⚠Investors should consider how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
6.20B
P/E Ratio (TTM)
9.00
Beta
0.24
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare GZPHF with peer companies:
- Price
- $9.37
- Market cap
- 4.20B
- Price
- $19.29
- Market cap
- 4.10B
- Price
- $39.08
- Market cap
- 4.16B
- Price
- $7.29
- Market cap
- 5.78B
- Price
- $5.50
- Market cap
- 5.84B
- Price
- $5.22
- Market cap
- 6.06B
- Price
- $14.55
- Market cap
- 6.84B
- Price
- $4.56
- Market cap
- 6.43B
- Price
- $7.60
- Market cap
- 5.64B
- Price
- $9.95
- Market cap
- 4.46B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.